Hemostemix Inc.
HMTXF
$0.04
$0.000.80%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.41% | -77.24% | -64.76% | -55.96% | -93.70% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -118.27% | -47.02% | 96.45% | 142.67% | 172.13% |
| Change in Net Operating Assets | -368.87% | -93.24% | -346.37% | -175.48% | 30.97% |
| Cash from Operations | -296.23% | -141.57% | -1,426.07% | -528.47% | -68.82% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.80% | -- | -- | -- | -- |
| Cash from Investing | 99.80% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 114.04% | 110.30% | -- | 847.02% | 248.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 96.94% | 92.45% | 34,178.52% | 846.97% | 308.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.95% | -105.02% | 436.08% | 1,223.40% | 479.48% |